Trial intelligence / Profile preview

ECT plus nortriptyline versus ECT plus placebo in major depressive disorder

NL-OMON33909Recruiting

Sponsor
Erasmus MC
Start
Mar 2010
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of nortriptyline in major depressive disorder (MDD) (3 arms), sponsored by Erasmus MC. Started Mar 2010; status: recruiting.

02

Drugs

nortriptyline
03

Conditions

major depressive disorder (MDD)

Beyond the preview

Go deeper on NL-OMON33909.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON33909.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call